Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones ...
Morning Overview on MSN
DNA-based system targets cancer cells, a step toward smarter drugs
Researchers have built DNA-based nanodevices that can identify cancer cells, latch onto them, and deliver drugs or ...
Researchers at Aarhus University have developed a microscopic DNA needle that can deliver molecules directly into cells—and, ...
Tunable DNA hairpin springs stretch millions of protein copies under piconewton tension, enabling bulk biochemical discovery ...
In 2021, the lab of chemical biologist and Nobel Laureate Carolyn Bertozzi, PhD, professor at Stanford University, characterized a new type of cell-surface protein, termed glycoRNAs, that form highly ...
With a new study in the journal Cell, researchers at Stanford University and Stockholm University have contributed to increased knowledge about gene regulation in human cells. How genes are turned on ...
In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.
Five years ago, Nobel laureate Carolyn Bertozzi, PhD, and her team described novel small RNA-glycan conjugates, glycosylated RNAs (glycoRNAs), on the cell surface. These small non-coding RNAs have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results